Articles
Plain explanations of what these assessments measure, written for the person having them and for the clinician reading the report.
-
Monofilament Test: What It Means When You Can’t Feel Your Feet
Failing a monofilament test marks a foot at risk and, in a ten-year diabetes cohort, a shorter life. What the filament checks, what it misses, and what else to measure.
-
Metabolic Screening in Chronic Pain: Who to Test and What Changes
Activity-limiting and multisite chronic pain predict cardiometabolic death. Who to screen, what fasting insulin, the TyG index and body composition add, and how to document it.
-
Low-Carb Diet Safety: A Physician’s Baseline and Re-Measure Plan
Before a patient restricts carbohydrate: the medication risks with published numbers, the autonomic, cognitive and body-composition baselines, and when each marker should be re-measured.
-
Dementia Prevention Starts With Numbers You Can Measure Now
The years before a dementia diagnosis are when correction works best. Which numbers a routine checkup misses, what Measura can measure, and when to measure again.
-
Ketogenic Diet, Mild Cognitive Impairment and the Screening Workup
Ketogenic therapy in MCI shows modest, reproducible effects in trials that excluded the insulin-resistant patient. What that means for baseline cognitive, metabolic and body-composition measurement.
-
Periodontal Disease and Dementia: A Screening Workflow
Severe periodontitis carries the dementia signal, GAIN excluded metabolically complex patients, and the dental chart rarely reaches the cognitive workup.
-
Gum Disease and Dementia: What Is Proven and What to Measure
Severe gum disease tracks with dementia risk, but the one drug trial failed. What the evidence shows, what Measura cannot test, and what it can measure.
-
Metaflammation Screening: What the Standard Panel Misses
Metaflammation is silent and the usual panel reads it late. Evidence tiers, who to measure, what the neutrophil count and waist add, and how to document it.